Pharmacometabolomics applied to low‐dose interleukin‐2 treatment in amyotrophic lateral sclerosisHugo Alarcan, Hélène Blasco, Christophe Masseguin et al.|Annals of the New York Academy of Sciences|2024Cited by 6